Last reviewed · How we verify

NCT04027244: LIMb

Leg Ischaemia Management Collaboration

Recruiting now Last updated 4 November 2020
What this trial tests

trial in Peripheral Arterial Disease in 420 participants. Currently enrolling.

Timeline
10 May 2019
Primary endpoint
9 May 2022
9 May 2031

Quick facts

Lead sponsorUniversity of Leicester
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment420
Start date10 May 2019
Primary completion9 May 2022
Estimated completion9 May 2031
Sites1 location across United Kingdom

Conditions studied

Sponsor

University of Leicester

Who can join

Adults 18 to 110, any sex, with Peripheral Arterial Disease or Critical Limb Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single-centre prospective cohort study of patients presenting with severe limb ischaemia (SLI). The primary outcome measure will be 12 month major amputation rate. A historical cohort of patients identified retrospectively will be the comparitor group used to assess the impact of a newly-established rapid-access limb salvage clinic. Primary aim: \- Determine the proportion of patients with SLI undergoing major lower limb amputation within 12 months of presentation. Secondary aims: * Assess clinically important short-, medium- and long-term outcomes in those undergoing and not undergoing amputation * Prevalence and degree of frailty and cognitive impairment * Pevalence and degree of cardiac disease (detected by stress MRI) * Establish a biobank for future biomarker analysis * Investigate the role of frailty and cognitive assessments, cardiac MRI and biomarkers in risk-stratification of patients with SLI

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. A systematic review of patient-reported outcome measures patients with chronic limb-threatening ischemia.
    Goodney P, Shah S, Hu YD, Suckow B, et al · · 2022 · cited 23× · PMID 35085747 · DOI 10.1016/j.jvs.2021.11.057
  2. Leg ischaemia management collaboration (LIMb): study protocol for a prospective cohort study at a single UK centre.
    Houghton JSM, Nduwayo S, Nickinson ATO, Payne TJ, et al · · 2019 · cited 7× · PMID 31481569 · DOI 10.1136/bmjopen-2019-031257
  3. Relationship of the Wound, Ischemia, and Foot Infection Stage with Frailty, Disability, Quality of Life, and One-Year Outcomes in All-Comers with Chronic Limb-Threatening Ischemia: Single-Center Prospective Cohort Study.
    Houghton JSM, Black I, Meffen A, Gray LJ, et al · · 2026 · cited 1× · PMID 41271091 · DOI 10.1016/j.avsg.2025.11.008

Verify or expand the search:

Other recruiting trials for Peripheral Arterial Disease

Currently open trials in the same condition.

Other University of Leicester trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04027244.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing